Comment
. 2008 Feb;15(2):394; author reply 394-5.
doi: 10.1128/CVI.00391-07.
Bordetella pertussis polymorphism and pertussis vaccines
- PMID: 18245622
- PMCID: PMC2238038
- DOI: 10.1128/CVI.00391-07
Item in Clipboard
Comment
Bordetella pertussis polymorphism and pertussis vaccines
Clin Vaccine Immunol.
2008 Feb.
No abstract available
Comment on
-
Pulsed-field gel electrophoresis, pertactin, pertussis toxin S1 subunit polymorphisms, and surfaceome analysis of vaccine and clinical Bordetella pertussis strains.Clin Vaccine Immunol. 2007 Nov;14(11):1490-8. doi: 10.1128/CVI.00177-07. Epub 2007 Aug 15. Clin Vaccine Immunol. 2007. PMID: 17699837 Free PMC article.
Similar articles
-
Bordetella pertussis and pertactin-deficient clinical isolates: lessons for pertussis vaccines.Expert Rev Vaccines. 2014 Sep;13(9):1135-46. doi: 10.1586/14760584.2014.932254. Epub 2014 Jun 23. Expert Rev Vaccines. 2014. PMID: 24953157 Review.
-
Use of Bordetella bronchiseptica and Bordetella pertussis as live vaccines and vectors for heterologous antigens.FEMS Immunol Med Microbiol. 2003 Jul 15;37(2-3):121-8. doi: 10.1016/S0928-8244(03)00068-3. FEMS Immunol Med Microbiol. 2003. PMID: 12832115 Review.
-
Bordetella pertussis epidemiology and evolution in the light of pertussis resurgence.Infect Genet Evol. 2016 Jun;40:136-143. doi: 10.1016/j.meegid.2016.02.032. Epub 2016 Feb 27. Infect Genet Evol. 2016. PMID: 26932577 Review.
-
Polymorphism in the Bordetella pertussis virulence factors P.69/pertactin and pertussis toxin in The Netherlands: temporal trends and evidence for vaccine-driven evolution.Infect Immun. 1998 Feb;66(2):670-5. doi: 10.1128/IAI.66.2.670-675.1998. Infect Immun. 1998. PMID: 9453625 Free PMC article.
-
Do Pertussis Vaccines Protect Against Bordetella parapertussis?Clin Infect Dis. 2017 Jun 15;64(12):1795-1797. doi: 10.1093/cid/cix221. Clin Infect Dis. 2017. PMID: 28369240
References
-
- Bottero, D., M. E. Gaillard, M. Fingermann, G. Weltman, J. Fernández, F. Sisti, A. Graieb, R. Roberts, O. Rico, G. Ríos, M. Regueira, N. Binsztein, and D. Hozbor. 2007. Pulsed-field gel electrophoresis, pertactin, pertussis toxin S1 subunit polymorphisms, and surfaceome analysis of vaccine and clinical Bordetella pertussis strains. Clin. Vaccine Immunol. 14:1490-1498. - PMC - PubMed
-
- Caro, V., V. Bouchez, N. Guiso, B. Gatti, M. R. Agosti, and S. E. Ayala. 2007. Pertussis in Argentina and France. Vaccine 25:4335-4339. - PubMed
-
- Caro, V., E. Njamkepo, S. C. Van Amersfoorth, F. R. Mooi, A. Advani, H. O. Hallander, Q. He, J. Mertsola, M. Riffelmann, C. Vahrenholz, C. H. Von König, and N. Guiso. 2005. Pulsed-field gel electrophoresis analysis of Bordetella pertussis populations in various European countries with different vaccine policies. Microbes Infect. 7:976-982. - PubMed
-
- Guiso, N., C. Capiau, G. Carletti, J. Poolman, and P. Hausser. 1999. Intranasal murine model of Bordetella pertussis infection. I. Prediction of protection in human infants by acellular vaccines. Vaccine 17:2366-2376. - PubMed
-
- Mooi, F. R., H. Hallander, C. H. Wirsing von König, B. Hoet, and N. Guiso. 2000. Epidemiological typing of Bordetella pertussis isolates: recommendations for a standard methodology. Eur. J. Clin. Microbiol. Infect. Dis. 19:174-181. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
